Companies / Hungary
Richter Snaps Up Regional Rivals
November 2007 | FDI AlertHungarian drugmaker Richter is set to become the largest pharmaceutical firm in the Central & Eastern European region with the purchase of Polish drugmaker Polpharma and Russia's Akrihin in a combined deal worth US$1.46bn. Richter's CEO Erik Bogsch claims the acquisitions will help Richter improve its product portfolio and gain critical mass, two key components of a successful generics firm, and an analysis BMI agrees with.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
